We develop and globally distribute new-concept of surgical staplers and minimally invasive surgical devices.
Making Surgical History
Since its establishment in April 2015, MEDITULIP Co., Ltd. has made remarkable achievements. Within one year since its establishment, it was selected for the TIPS program for the first time as a national university (September 2015), certified as a venture firm, registered four domestic patents, two international patents and filed eight international applications as well as two PCT application. We also registered 1 domestic patent and filed 1 PCT for a chemoport.
Moreover, we have obtained a factory site within the Osong Bio-Health Science Technopolis and plan to manufacture products in 2018.
Furthermore, we established MEDITULIP Global, Inc., a sales and market access company, to expedite the distribution of MEDITULIP products domestically and overseas and to import innovative products from abroad.
We will continue to make a second and a third "Surgical History" through continuous research and development based on our technological and development skills. MEDITULIP Co., Ltd. promises to serve as the light and the salt of the world, contributing to the human welfare through continuous innovation, services, and donations.
CEO of Meditulip Co., Ltd.
Thoracic Surgery Department Professor
Chungnam National University Hospital Min-Woong Kang
MD/PhD, CEO of MEDITULIP Co., Ltd., Associate Professor, Chief of Thoracic Division, Department of Thoracic and Cardiovascular Surgery, Chungnam National University.
National Institute of Medical Device Safety Information (NIDS): Advisor for medical device problems
KFDA: Advisory panel member of Medical device
Deputy of Director, Korean Society of Thoracic and Cardiovascular Surgery
Faculty member of ATCCS 2018, Hong Kong
Faculty member of ATSOP 2017, Singapore
Faculty member of 2nd Asian single port VATS surgery symposium
Member of The Korean Society for Thoracic and Cardiovascular Surgery
Member of The Korean Association for Lung Cancer Society
Member of The Korean society for Thoracic Surgical Oncology
Member of International Association for the Study of Lung Cancer
Member of Korean Association for the Study of Lung Cancer
Editorial Board member of Korean Association for the Study of Lung Cancer (Journal of Lung Cancer)
Scientific committee member of The Korean Society for Thoracic and Cardiovascular Surgery
Scientific committee member of The Korean Society for Thoracic Oncologic Surgery
2010 : Johnson and Johnson Medical award
2009 : Scientific award of Korean Society for Thoracic and Cardiovascular Surgery.
CEO of MEDITULIP Global, Inc.
Country Manager at Intuitive Surgical KOREA
Head of Strategic Planning and Head of Marketing at Samsung Medison
Marketing Director at Stryker KOREA
Senior Consultant at IBM GBS
Vice President at Nemo Partners
BS degree in chemistry and MS in biochemistry from Seoul National University
MBA from Kellogg School of Management
Business Fields - Introduction of Products
Development of a Minimal Invasive Surgical Device
We develop new-concept staplers that innovatively remedy the drawbacks of existing linear staplers by obtaining an original patent that secures resection margin, a fundamental principle of cancer operation, as well as a minimal invasive surgical device with staplers at its core.
Suggestions for a New Paradigm for Cancer Operation
The worldwide surgical stapler market has a monopolistic market structure in which Medtronic and Johnson & Johnson Medical occupy approximately 93% of the entire market. Through its technological skills, Meditulip Co., Ltd. plans to suggest a new paradigm for cancer operation and to secure a bridgehead for developing international markets based on the substitution effect in domestic market products and technological dominance.
MediTulip Global will continue to develop distribution partnerships with emerging companies abroad to bring innovative products into the region.
TIPSO™ Touchless Image Navigation
PERFORMANCE - Patents and Investments
Articles and Patents
1 domestic patent registered and 1 PCT filed for chemoports.
Meditulip suggests a new paradigm for cancer operation
MEDITULIP plant (GMP) opened
MEDITULIP Seoul Office opened
국내 VC로부터 Series B (43억원) 투자 유치
MEDITULIP Global, Inc. established 2018. 07. 26.
Obtained approval of moving into the land of Osong bio-Health Science Technopolis.
Establishment of a branch office in China(Shanghai).
Attracted Series A (about 1.5billion won) investment from Domestic VC.
Agreed an investment contract with Chungcheongbuk-do along with Medical venture companies.
Appeared on SBS CNBC 'The Eye of Enterprise that sees the Future Leader' + view
Visited five major medical stapler manufacturing companies in China and discussed cooperation plans for international market expansion
Selected as a Chungcheongbuk-do Province Innovative Medical Technology Value-creating Enterprise and developed a cooperation structure with the Osong Medical Innovation Foundation
Obtained a new technology patent for a surgical stapler that can secure tissues for pathological examination
Held the Meditulip Co., Ltd. Medical Device Manufacturing TFT Workshop, which was participated in by institutions in cooperation, including the Osong Medical Innovation Foundation and Ji-Yool, a patent law firm
Made industry–university cooperation and venture firm established by university faculty investment agreement (Chungnam Industry–University Cooperation – ActnerLab – Meditulip Co., Ltd.)
Selected as a Chungbuk Industry–University Cooperation R&D Enterprise and for the TIPS program (first case for a company established by a national university faculty), and certified as a venture firm
Opened the Osong office of Meditulip Co., Ltd.: Moved into the Osong Bio-Health Science Technopolis and qualified for various benefits under the Enforcement Decree of the Special Act on the Designation and Support of High-tech Medical Complexes (Presidential Decree No. 24454, March 23, 2013)
Founded Meditulip Co., Ltd., a corporation established by a university faculty
Obtained a new technology patent for a surgical stapler with double blades
MEDITULIP HQ & Manufacturing
34, Uiryodanji-gil, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea
MEDITULIP Seoul Office and MEDITULIP Global, Inc.
6th Floor, Dongwon Building, 13 Teheran-ro 81-Gil, Gangnam-gu, Seoul, Republic of Korea (Zip 06168)
Room 601, 3 building, No.168, shangghai east road, Loudong street, Taicang city, China 215400 江苏省苏州市太仓市城厢镇娄东街道上海东路168号3幢601室